Favorable outcome of adjunctive traditional Chinese medicine therapy in liver cirrhosis: A large cohort study in Southwest China-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Favorable outcome of adjunctive traditional Chinese medicine therapy in liver cirrhosis: A large cohort study in Southwest China

Published:2020-06 Issue: Volume:51 Page:102446
ISSN:0965-2299
Container-title:Complementary Therapies in Medicine
language:en
Short-container-title:Complementary Therapies in Medicine

Author:

Xie Zhihao,Qiang Jian,Pi Xiaobing,Wang Jingxuan,Chen Yuhong,Yu Qian,Zhang Qiang

Publisher

Elsevier BV

Subject

Advanced and Specialized Nursing,Complementary and alternative medicine,Complementary and Manual Therapy

Reference32 articles.

1. Liver cirrhosis;Tsochatzis;Lancet,2014

2. Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017;Zhou;Lancet,2019

3. Study of liver cirrhosis over ten consecutive years in Southern China;Wang;World J Gastroenterol,2014

4. The global burden of liver disease: the major impact of China;Wang;Hepatology,2014

5. Epidemiology of alcoholic and nonalcoholic fatty liver disease in China;Fan;J Gastroenterol Hepatol,2013

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sixteen prescribed Chinese herbal medicines provide time-dependent cardiorenal and survival benefits in patients with overall and advanced diabetic kidney disease: a real-world study in Taiwan;Frontiers in Pharmacology;2024-08-22

2. YinChen WuLing powder attenuates non-alcoholic steatohepatitis through the inhibition of the SHP2/PI3K/NLRP3 pathway;Frontiers in Pharmacology;2024-07-19

3. Effects and mechanisms of Xiaochaihu Tang against liver fibrosis: An integration of network pharmacology, molecular docking and experimental validation;Journal of Ethnopharmacology;2023-03

4. Probiotic management and inflammatory factors as a novel treatment in cirrhosis: A systematic review and meta-analysis;Open Life Sciences;2023-01-01

5. Exploring mechanisms of Chaihu-Shugan-San against liver fibrosis by integrated multi-omics and network pharmacology approach;Bioscience Reports;2022-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3